J. B. Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM)

India flag India · Delayed Price · Currency is INR
1,882.55
+28.50 (1.54%)
Oct 30, 2024, 3:29 PM IST
38.31%
Market Cap 291.80B
Revenue (ttm) 35.92B
Net Income (ttm) 5.87B
Shares Out n/a
EPS (ttm) 36.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date Aug 14, 2024
Volume 147,735
Open 1,850.55
Previous Close 1,854.05
Day's Range 1,850.55 - 1,910.00
52-Week Range 1,371.00 - 2,030.00
Beta -0.04
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About JBCHEPHARM

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-cen... [Read more]

Sector Healthcare
Founded 1976
Employees 5,311
Stock Exchange National Stock Exchange of India
Ticker Symbol JBCHEPHARM
Full Company Profile

Financial Performance

In 2023, JBCHEPHARM's revenue was 34.84 billion, an increase of 10.63% compared to the previous year's 31.49 billion. Earnings were 5.53 billion, an increase of 34.84%.

Financial Statements

News

Stocks to Buy This Diwali: Kotak Securities sees JB Chemicals & Pharma reaching ₹2,255, with a 19.2% upside

Kotak Securities has added JB Chemicals & Pharma to its Diwali 2024 stock picks, assigning it a “Buy” rating with a target price of ₹2,255. Currently trading at ₹1,891, JB Chemicals offers an upside p...

5 days ago - Business Upturn

Pharma Stocks Update: Natco Pharma gains 2.99%, Glenmark rises 0.07%, Granules falls 3.83%

As of 2:38 PM, the Nifty Pharma index saw a mixed performance with some stocks showing notable gains while others faced losses. Natco Pharma, Glenmark, and Ajanta Pharma were the top gainers, while Gr...

24 days ago - Business Upturn

Pharma Stocks Update: Granules up 3.56%, Ajanta Pharma gains 2.24% while JB Chemicals drops 2.82%, Mankind Pharma down 1.40% in mixed pharma stock performance

Pharma stocks have shown mixed performance in today’s trading session, with some major players gaining ground while others face declines. As of now, here’s how key pharmaceutical stocks are performing...

4 weeks ago - Business Upturn

JB Chemicals faces valuation dispute over KKR’s 54% equity stake, potential M&A deal withdrawal looms; stock falls 4.28%

The largest M&A deal in India’s pharmaceutical industry for 2024 is reportedly facing significant hurdles. According to ET Now, JB Chemicals is in a disagreement over the valuation of KKR’s 54% equity...

5 weeks ago - Business Upturn